Sign in

Research summary ·

Efficacy of Platelet-Rich Plasma in the Management of Oral Potentially Malignant Disorders - A Systematic Review.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This review looked at platelet-rich plasma, or PRP, for some mouth sores. These sores carry a raised risk of turning into mouth cancer. Doctors call them oral potentially malignant disorders. The team searched PubMed, Scopus, Embase and Google Scholar. They kept only randomised trials written in English. People in the trials were adults aged 18 or more. They got PRP and no other care at the same time. The team checked each trial for bias and summed up the results in words.

What they found

The authors say early results look good for PRP. Gains were seen in how the sores looked. Gains were also seen in tissue tests. This was most clear in oral lichen planus. PRP was set against steroid drugs. It did well at making sores smaller. It also eased symptoms and helped the mouth lining heal. Side effects were few, the abstract says.

What it means for patients

The authors think PRP may work as an add-on to usual care. They also think it may work in place of usual care. This view rests on the early trials in the review. The authors do not yet call it a settled care plan.

Why it is not certain yet

The authors call these findings early. They say large, well-run trials are still needed. Such trials could set a standard way to give PRP. They could also show if PRP works and is safe in the long run. The abstract does not give the number of trials or people. A review can only be as good as the studies in it.

Source

Efficacy of Platelet-Rich Plasma in the Management of Oral Potentially Malignant Disorders - A Systematic Review.

PubMed · PMID 42446315

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Head and neck cancer publications